Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NanoSALV Catalytic vs Standard Topical Care Pathway in Sports-Related Skin Lesions
NCT07807904Phase 3Not yet recruiting
- Start
- Oct 2026
- Primary completion
- May 2027
01
Overview
Phase 3, randomised, double-blind trial in Friction Blister (2 arms). Primary endpoint: Blister Area at 14 days. Planned start Oct 2026; status: not yet recruiting.
02
Conditions
Friction Blister
Beyond the preview
Go deeper on NCT07807904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07807904.